Search research articles
Contact Us
Filters
Showing results (171-180 of 1,827) with videos related to
Page
of 183
Sort By:
Vascular Medicine (London, England)
|
April 25, 2003
Pharmacologic treatment for intermittent claudication
Steven M Dean
Physics in Medicine and Biology
|
October 1, 1970
Modification of a counting ratemeter to reduce the effect of statistical fluctuations
P M Dean
The Journal of Pharmacy and Pharmacology
|
March 1, 1996
hP, the component of log P controlling structure-activity relationships amongst non-steroidal anti-inflammatory drugs
F M Dean
EMBO Reports
|
June 2, 2010
The future of molecular evolution
Antony M Dean
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Structural Examination of 6-Methylsulphonylphenanthro- [9,10-C]-furan-1(3H)-one-A Rofecoxib Degradation Product
Pamela M Dean
The Functional Orthodontist
|
May 1, 1992
The addition of composite to the occlusal surfaces in order to alter condyle/fossa relationships
R M Dean
American Family Physician
|
September 1, 2005
Alternative to liquid nitrogen for freezing skin lesions
M Dean Havron
Genetics
|
November 17, 2004
Protecting haploid polymorphisms in temporally variable environments
Antony M Dean
Current Opinion in Biotechnology
|
February 19, 2002
Functional genomics and target validation approaches using antisense oligonucleotide technology
N M Dean
Transfusion
|
September 13, 2006
Is it time to focus on preserving the functionality of red blood cells during storage?
M Dean Elfath
Page
of 183
Search research articles
Search
Showing results (171-180 of 1,827) with videos related to
Sort By:
Page
of 183
Vascular Medicine (London, England)
|
April 25, 2003
Pharmacologic treatment for intermittent claudication
Steven M Dean
Physics in Medicine and Biology
|
October 1, 1970
Modification of a counting ratemeter to reduce the effect of statistical fluctuations
P M Dean
The Journal of Pharmacy and Pharmacology
|
March 1, 1996
hP, the component of log P controlling structure-activity relationships amongst non-steroidal anti-inflammatory drugs
F M Dean
EMBO Reports
|
June 2, 2010
The future of molecular evolution
Antony M Dean
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Structural Examination of 6-Methylsulphonylphenanthro- [9,10-C]-furan-1(3H)-one-A Rofecoxib Degradation Product
Pamela M Dean
The Functional Orthodontist
|
May 1, 1992
The addition of composite to the occlusal surfaces in order to alter condyle/fossa relationships
R M Dean
American Family Physician
|
September 1, 2005
Alternative to liquid nitrogen for freezing skin lesions
M Dean Havron
Genetics
|
November 17, 2004
Protecting haploid polymorphisms in temporally variable environments
Antony M Dean
Current Opinion in Biotechnology
|
February 19, 2002
Functional genomics and target validation approaches using antisense oligonucleotide technology
N M Dean
Transfusion
|
September 13, 2006
Is it time to focus on preserving the functionality of red blood cells during storage?
M Dean Elfath
Page
of 183